 Mohd Minhajuddin
Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bridged Bicyclo Compounds, Heterocyclic | 4 | 2025 | 293 | 0.980 |
Why?
| | Sulfonamides | 4 | 2025 | 596 | 0.860 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2025 | 128 | 0.800 |
Why?
| | Intercellular Adhesion Molecule-1 | 7 | 2009 | 132 | 0.750 |
Why?
| | Neoplastic Stem Cells | 2 | 2025 | 409 | 0.720 |
Why?
| | Protein Kinase Inhibitors | 3 | 2025 | 984 | 0.690 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 4 | 2025 | 2001 | 0.560 |
Why?
| | Thrombin | 7 | 2009 | 174 | 0.480 |
Why?
| | NF-kappa B | 5 | 2008 | 676 | 0.440 |
Why?
| | Azacitidine | 3 | 2024 | 168 | 0.390 |
Why?
| | Protein Kinase C-delta | 2 | 2008 | 45 | 0.340 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2024 | 700 | 0.340 |
Why?
| | Endothelial Cells | 4 | 2009 | 886 | 0.310 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 51 | 0.280 |
Why?
| | Transcription Factor RelA | 5 | 2009 | 93 | 0.270 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 383 | 0.240 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 440 | 0.240 |
Why?
| | Neoplasm, Residual | 2 | 2024 | 144 | 0.240 |
Why?
| | Blast Crisis | 1 | 2025 | 34 | 0.220 |
Why?
| | Carrier Proteins | 1 | 2008 | 731 | 0.210 |
Why?
| | Endothelium, Vascular | 3 | 2006 | 959 | 0.210 |
Why?
| | Protein Kinases | 1 | 2005 | 312 | 0.190 |
Why?
| | Gene Expression Regulation | 3 | 2008 | 2625 | 0.160 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 280 | 0.150 |
Why?
| | Cell Nucleus | 3 | 2009 | 589 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 889 | 0.140 |
Why?
| | Phosphorylation | 5 | 2009 | 1721 | 0.130 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3565 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2022 | 703 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2008 | 432 | 0.100 |
Why?
| | Benzofurans | 1 | 2014 | 26 | 0.100 |
Why?
| | Triterpenes | 1 | 2014 | 27 | 0.100 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2008 | 456 | 0.100 |
Why?
| | Mutation | 1 | 2024 | 4130 | 0.090 |
Why?
| | Mice | 3 | 2025 | 18491 | 0.090 |
Why?
| | NF-KappaB Inhibitor alpha | 3 | 2009 | 50 | 0.090 |
Why?
| | I-kappa B Proteins | 3 | 2009 | 75 | 0.090 |
Why?
| | Leukemia | 1 | 2014 | 247 | 0.090 |
Why?
| | Cell Line | 2 | 2008 | 2832 | 0.080 |
Why?
| | Phosphotyrosine | 2 | 2008 | 38 | 0.080 |
Why?
| | Hemostatics | 2 | 2008 | 65 | 0.080 |
Why?
| | Cofilin 1 | 1 | 2009 | 5 | 0.070 |
Why?
| | I-kappa B Kinase | 2 | 2008 | 52 | 0.070 |
Why?
| | Sirolimus | 2 | 2014 | 283 | 0.070 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2008 | 36 | 0.070 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 234 | 0.070 |
Why?
| | Animals | 3 | 2025 | 38410 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2008 | 762 | 0.060 |
Why?
| | Humans | 12 | 2025 | 147293 | 0.060 |
Why?
| | Signal Transduction | 3 | 2008 | 5272 | 0.060 |
Why?
| | Cytoskeleton | 1 | 2006 | 193 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 459 | 0.050 |
Why?
| | Actins | 1 | 2006 | 428 | 0.050 |
Why?
| | Drug Synergism | 1 | 2005 | 355 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2004 | 208 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 264 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2006 | 627 | 0.050 |
Why?
| | Fibroblasts | 1 | 2008 | 1039 | 0.050 |
Why?
| | Down-Regulation | 1 | 2005 | 618 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2231 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 88 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2008 | 3153 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2024 | 1046 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2022 | 779 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2024 | 8430 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 17560 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1151 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1488 | 0.030 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2008 | 117 | 0.030 |
Why?
| | DNA | 3 | 2008 | 1444 | 0.030 |
Why?
| | Prognosis | 1 | 2024 | 4383 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 2 | 2009 | 480 | 0.030 |
Why?
| | Adult | 3 | 2024 | 41405 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2008 | 4169 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 2014 | 90 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2006 | 2812 | 0.020 |
Why?
| | Aged | 2 | 2024 | 26514 | 0.020 |
Why?
| | Protein Binding | 2 | 2008 | 2249 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2014 | 590 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 616 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2014 | 939 | 0.020 |
Why?
| | Middle Aged | 2 | 2024 | 36821 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 536 | 0.020 |
Why?
| | Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 630 | 0.020 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 76 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11947 | 0.020 |
Why?
| | rho-Associated Kinases | 1 | 2009 | 82 | 0.020 |
Why?
| | Syk Kinase | 1 | 2008 | 19 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 334 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1457 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 442 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 477 | 0.020 |
Why?
| | Mitochondria | 1 | 2014 | 1000 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1794 | 0.020 |
Why?
| | Phosphoserine | 1 | 2006 | 25 | 0.020 |
Why?
| | Dimerization | 1 | 2006 | 189 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2008 | 372 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2006 | 93 | 0.010 |
Why?
| | RNA Stability | 1 | 2006 | 108 | 0.010 |
Why?
| | Phenotype | 1 | 2014 | 3216 | 0.010 |
Why?
| | Male | 2 | 2024 | 73950 | 0.010 |
Why?
| | Apoptosis | 1 | 2014 | 2454 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14437 | 0.010 |
Why?
| | Female | 2 | 2024 | 80076 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1253 | 0.010 |
Why?
| | Umbilical Veins | 1 | 2004 | 58 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 2006 | 507 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 451 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1224 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1772 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1135 | 0.010 |
Why?
|
|
Minhajuddin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|